Metropolitan Life Insurance Company (MetLife)’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,846
| Closed | -$36.4K | – | 1125 |
|
|
2024
Q1 | $36.4K | Hold |
1,846
| – | – | ﹤0.01% | 1561 |
|
|
2023
Q4 | $32.4K | Hold |
1,846
| – | – | ﹤0.01% | 1667 |
|
|
2023
Q3 | $32.1K | Hold |
1,846
| – | – | ﹤0.01% | 1644 |
|
|
2023
Q2 | $26K | Buy |
+1,846
| New | +$26K | ﹤0.01% | 1788 |
|
|
2023
Q1 | – | Sell |
-1,846
| Closed | -$27.7K | – | 2395 |
|
|
2022
Q4 | $27.7K | Hold |
1,846
| – | – | ﹤0.01% | 1832 |
|
|
2022
Q3 | $23.7K | Hold |
1,846
| – | – | ﹤0.01% | 1936 |
|
|
2022
Q2 | $17.9K | Hold |
1,846
| – | – | ﹤0.01% | 2093 |
|
|
2022
Q1 | $18.3K | Sell |
1,846
-2,907
| -61% | -$28.9K | ﹤0.01% | 2133 |
|
|
2021
Q4 | $55.9K | Buy |
4,753
+180
| +4% | +$2.12K | ﹤0.01% | 2690 |
|
|
2021
Q3 | $52.1K | Buy |
+4,573
| New | +$52.1K | ﹤0.01% | 2755 |
|
|
2021
Q2 | – | Sell |
-7,548
| Closed | -$140K | – | 2795 |
|
|
2021
Q1 | $140K | Sell |
7,548
-890
| -11% | -$16.5K | ﹤0.01% | 2254 |
|
|
2020
Q4 | $149K | Hold |
8,438
| – | – | ﹤0.01% | 2136 |
|
|
2020
Q3 | $129K | Buy |
8,438
+2,221
| +36% | +$34K | ﹤0.01% | 2071 |
|
|
2020
Q2 | $158K | Buy |
6,217
+1,225
| +25% | +$31.2K | ﹤0.01% | 1963 |
|
|
2020
Q1 | $77.3K | Buy |
+4,992
| New | +$77.3K | ﹤0.01% | 2195 |
|